Skip to content
ProPublica Donate
ProPublica Donate
Health Care

Omniscan

Specter of MRI Disease Haunts General Electric

General Electric is in a liability fight over a rare disease that has been linked to dyes used in MRIs. Nearly all cases of the disease, nephrogenic systemic fibrosis, have involved people with kidney problems who used the dyes, but GE says there is no proof that its product, Omniscan, causes the crippling illness.

GE Failed to Adequately Warn about Dangers of its MRI Dye, Jury Finds

by Jeff Gerth,

'Burn the Data': Did a Company Try to Hide Risks of MRI Dye Omniscan?

by Jeff Gerth,

Late Settlement Averts First Jury Test For Allegations Against General Electric’s Omniscan

by Jeff Gerth,

General Electric Faces First Jury Test in Omniscan Litigation

by Jeff Gerth,

FDA Acts to Restrict GE’s Omniscan MRI Drug, and Two Others

by Jeff Gerth,

Omniscan: The Story So Far

by ProPublica,

GE Violated Danish Drug Reporting Law in Omniscan Case

by Jeff Gerth,

Judge Opens Door to Case Against General Electric’s Omniscan

by Jeff Gerth,

GE’s Own Safety Team Urged Company to Restrict MRI Drug

by Jeff Gerth,

GE and Muzzled Radiologist End UK Libel Case

by Jeff Gerth,

Paulson Book: Behind the Scenes, GE’s Top Exec Confided Credit Woes

by Jeff Gerth,

GE Suit Hushes Scientist Critical of Omniscan

by Jeff Gerth,

FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs

by Jeff Gerth,

Feds May Tighten Rules on Omniscan, a GE MRI Drug

by Jeff Gerth,

FDA to Take a Second Look at Warnings on MRI Drugs

by Jeff Gerth,

Specter of MRI Disease Haunts GE

by Jeff Gerth,